Home
About
Journal Issues
In Press
Video Article
Indexing and Citation Metrics
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
1735-403X
eISSN
:
2383-2886
Submit Your Paper
Editorial Board
Instructions for Authors
Instructions for Reviewers
Contact Us
Editorial Policies
Peer Review
Archive
Follower of ICMJE
Powered by:
Pharm Sci
. 2021;27(3): 302-312. doi:
10.34172/PS.2020.97
Review
The Role of HSA21 Encoded Mirna in Down Syndrome Pathophysiology:Opportunities in miRNA-Targeted Pharmacotherapy and Diagnosis of the Down Syndrome
Shabnam Mahernia
1
, Sajad Sarvari
2
, Yousef Fatahi
3
,
4
,
5
, Massoud Amanlou
1
,
6
*
Cited by CrossRef: 1
1- Sessa R, Trombetti S, Bianco A, Amendola G, Catapano R, Cesaro E, Petruzziello F, D'Armiento M, Maruotti G, Menna G, Izzo P, Grosso M. miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1 S expression .
Open Biol
. 2024;14(2)
[Crossref]
Indexing & Abstracting:
Follow us on LinkedIn
Follow us on Twitter